Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

NCT01102335 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: Transcatheter arterial chemoembolization (TACE)
DRUG: Telbivudine

Sponsor

Fudan University